Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Impact of BRAF-V600E mutation on the tumour microenvironment and associated genomic alterations in colorectal cancer

Dr Mohamed Salem - Levine Cancer Institute, Charlotte, USA
Impact of BRAF-V600E mutation on the tumour microenvironment and associated genomic alterations in colorectal cancer ( Dr Mohamed Salem - Levine Cancer Institute, Charlotte, USA )
20 Jul 2022

New developments in the treatment of colorectal malignancies

Dr Richard Kim - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA
New developments in the treatment of colorectal malignancies ( Dr Richard Kim - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA )
8 Jul 2022

Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer

Dr Mustafa Kamani - Hacettepe University Faculty of Medicine, Ankara, Turkey
Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer ( Dr Mustafa Kamani - Hacettepe University Faculty of Medicine, Ankara, Turkey )
30 Jun 2022

Cancer patient symptom and physical function reporting by caregivers used as predictors of adverse clinical outcomes

Dr Elad Neeman - Kaiser Permanente San Francisco Medical Center, San Francisco, USA
Cancer patient symptom and physical function reporting by caregivers used as predictors of adverse clinical outcomes ( Dr Elad Neeman - Kaiser Permanente San Francisco Medical Center, San Francisco, USA )
21 Jun 2022

War in Ukraine: Global cancer aid to support refugees

Dr Horia Vulpe , Dr Ruslan Baltaga
War in Ukraine: Global cancer aid to support refugees ( Dr Horia Vulpe , Dr Ruslan Baltaga )
21 Jun 2022

RAGNAR study evidences efficacy and safety of erdafitinib in patients with advanced FGFR+ malignancies

Dr Yohann Loriot - Institut Gustave Roussy, Villejuif, France
RAGNAR study evidences efficacy and safety of erdafitinib in patients with advanced FGFR+ malignancies ( Dr Yohann Loriot - Institut Gustave Roussy, Villejuif, France )
17 Jun 2022

ASCO and WHO to collaborate on quality indicators for cancer facilities

Dr André Ilbawi - WHO Headquarters, Geneva, Switzerland
ASCO and WHO to collaborate on quality indicators for cancer facilities ( Dr André Ilbawi - WHO Headquarters, Geneva, Switzerland )
14 Jun 2022

Spotlight on global cancer control at ASCO 2022

Prof Eduardo Cazap - Editor-in-Chief, ecancer and SLACOM
Spotlight on global cancer control at ASCO 2022 ( Prof Eduardo Cazap - Editor-in-Chief, ecancer and SLACOM )
10 Jun 2022

UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries

Dr Cary Adams - Chief Executive Officer, Union for International Cancer Control
UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries ( Dr Cary Adams - Chief Executive Officer, Union for International Cancer Control )
9 Jun 2022

ASCO 2022: Highlights and analysis

Dr Bishal Gyawali - Queen's University, Kingston, Canada
ASCO 2022: Highlights and analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
6 Jun 2022

ctDNA sequencing detects outcomes for pretreated advanced gastrointestinal stromal tumour

Dr César Serrano - Vall d'Hebron Institute of Oncology, Barcelona, Spain
ctDNA sequencing detects outcomes for pretreated advanced gastrointestinal stromal tumour ( Dr César Serrano - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
6 Jun 2022

FOLFOXIRI plus panitumumab vs mFOLFOX6/PAN for unresectable RAS and BRAF wild-type mCC

Dr Chiara Cremolini - University of Pisa, Pisa, Italy
FOLFOXIRI plus panitumumab vs mFOLFOX6/PAN for unresectable RAS and BRAF wild-type mCC ( Dr Chiara Cremolini - University of Pisa, Pisa, Italy )
6 Jun 2022